GUPharma, based in the Dominican Republic, stands at the forefront of the pharmaceutical industry as a leading Contract Research, Development, and Manufacturing Organization (CDMO). Dedicated to driving innovation and excellence, GUPharma collaborates with over 300 global innovator pharmaceutical and biotech companies, specializing in the acceleration of discovery, development, and commercialization of New Chemical Entities (NCEs) in the small molecule sector.

With a strong legacy spanning over two decades, GUPharma has effectively supported a wide array of programs, consistently adding value through its commitment to quality and swift responsiveness. The company employs over 3,000 skilled professionals and operates state-of-the-art facilities across strategic locations in the Dominican Republic, with a global presence in the UK, USA, and Japan. This expansive network underpins its capability to meet complex research and production demands at scale, fostering advancements in medicine and treatment options worldwide.